JUN 25, 2020 7:54 AM PDT

Using RNA to Predict Acute Ischemic Strokes

WRITTEN BY: Jasper Cantrell

Strokes are a leading cause of death and long term-disability across the globe. Ischemic strokes (IS) or acute ischemic strokes (AIS), compose the bulk of these cases. The diagnosis and treatment of AIS have improved over the years, although it is still plagued with high mortality and disability rates. Thrombolysis, or the treatment of a blood clot using drugs, is the universally accepted first-line treatment. However, recombinant tissue plasminogen activator (rt-PA) is currently the only FDA approved drug for thrombolysis.

A popular new area of drug research is the study of RNA. In the last two decades, new forms of RNA have been discovered that have essential roles in regulating many processes in the body. Circular RNA (circRNA) is one such group.

CircRNA is, rather straight-forwardly, characterized by its circular structure. They are thought to act as regulating “sponges” for other RNA groups like microRNAs. MicroRNAs, which usually regulate the genome, would instead bind to these circRNAs. Many circRNAs, such as circNT5E and circMTO, are already linked to the suppression of tumors. CircTLK1 has even been linked to IS in one study. A group from Guangxi Medical University in China hypothesized that a study of differentially expressed (DE) circRNAs could identify key biomarkers that could predict the likelihood of IS in a patient.

They began by collecting samples from sixty-four local patients, half healthy patients, and half AIS patients. Two thousand two hundred and seventy DE circRNAs were identified in an initial screen, and the group chose the top thirty amongst them for this study. They made a note that the DE profile surprisingly resembled what could be seen in pathological brain damage profiles.

Narrowing the study pool even further to the top ten DE circRNAs, they used a prediction tool to find miRNAs that they would bind to. Three of these ten were predicted to bind miRNAs associated with the cell death pathway apoptosis. They inferred that these miRNAs might also have some role in blood clot formation. More importantly, all three were clearly dysregulated in AIS patients versus healthy patient’s blood samples, making them possible diagnostic biomarkers.

While this was primarily a screening project, the group managed to link the dysregulation of at least three circRNAs to AIS. AIS, by definition, is sudden, and an effective treatment relies on the speed at which the patient can be treated. Therefore, diagnostic tools predicting AIS in a patient would be a critical tool to prevent a fatal AIS. Using circRNAs, doctors could predict the likelihood of AIS in a patient just by doing a blood test.

The team concludes, “The finding of this study may help future researchers to identify new circulating diagnostic biomarkers, understand the pathologic process of AIS and identify therapeutic targets for AIS.”

Sources: Nature Scientific Reports, Barrow Neurological Institute
 

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
MAR 18, 2021
Cardiology
Searching for New Cardiovascular Biomarkers
MAR 18, 2021
Searching for New Cardiovascular Biomarkers
Do you want to know what the best medicine for cardiovascular health is? It isn't some heart-shaped pill with some m ...
JUN 29, 2021
Immunology
The Heartbreaking Nature of COVID Revealed
JUN 29, 2021
The Heartbreaking Nature of COVID Revealed
Researchers at the Washington University School are getting to the root of heart damage resulting from COVID-19 infectio ...
JUL 16, 2021
Cardiology
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
JUL 16, 2021
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
When the flow of blood to the heart is blocked, heart cells don't get enough oxygen and begin to die; this is a heart at ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 01, 2021
Technology
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
SEP 01, 2021
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
Recent guidance by the U.S Food and Drug Administration (FDA) recommended that people with implanted medical devices sho ...
SEP 26, 2021
Cardiology
New Type of Artificial Heart Tested in Several Patients Shows Promise
SEP 26, 2021
New Type of Artificial Heart Tested in Several Patients Shows Promise
In July, a new type of artificial heart was been implanted for the first time in a US patient at Duke University Medical ...
Loading Comments...